Extreme transaminase elevation in acute heart disease is typically a result of ischemic liver injury (central necrosis) driven by right ventricular failure and hypotension, rather than primary hepatic disease.
Answers are grounded in this paper and cite their sources.
Extreme transaminase rises in acute cardiac disease may signal ischemic hepatitis from RV failure plus hypotension; case reports leave open prospective validation.
Five patients admitted to the Coronary Care Unit at the Department of Medicine, Serafimerlasarettet, who developed extreme elevation of transaminase levels, are discussed in terms of problems in differential diagnosis. All five had manifest right ventricular failure on admission and four also had hypotension. Three of the patients died, two survived. The three post-mortem examinations showed extensive infarctions of the left ventricle and septum. The two survivors had had a prolonged ventricular tachycardia and a probable silent infarct, respectively. It is concluded that the extremely high transaminase levels sometimes seen in acute cardiac disease are predominantly due to sizeable amounts released by the liver as a result of central necrosis of the liver cells. The probable prerequisite for the development of central necrosis of the liver in acute cardiac disease is usually the combination of right ventricular failure and hypotension, which in turn are most often due to extensive left ventricular infarcts.
No takes yet. Share an insight, caveat, or question.
Bloth et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: